Blog

Read the last news about N-SIDE

Filter Resources

Woops, there's no exact match to what you are looking for. But we selected relevant content that you might also be interested in:

The challenges of a cell & gene therapy supply chain - part 4 Read more The challenges of a cell & gene therapy supply chain - part 3 Read more For the first time, meet N-SIDE in Singapore at the CTFA 2023 Read more

purple background with DNA strand picture

The challenges of a cell & gene therapy supply chain - part 4

Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 4] - Forecasting CGT demand and adapting the supply...

purple background with image of DNA strand

The challenges of a cell & gene therapy supply chain - part 3

Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 3] - Optimal manufacturing capacity

Purple background picture of Singapore with IMAPAC & N-SIDE logos

For the first time, meet N-SIDE in Singapore at the CTFA 2023

N-SIDE is attending its first industry event in the APAC region with the CTFA Singapore this March 2023. After onboarding Marine du Jardin as N-SIDE's new APAC...

The challenges of a cell & gene therapy supply chain - part 2

Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 2] - Probabilistic simulations and digital twin for...

Image showing a picture of Sandrine Dury the new N-SIDE Life Sciences Managing Director

N-SIDE welcomes Sandrine Dury as new Life Sciences Managing Director

Sandrine Dury arrives at N-SIDE this November to take the lead of its Life Sciences Business Unit Louvain-la-Neuve, November 23 - N-SIDE, a leading provider of...

Empowering life sciences companies to accurately monitor and manage all supply risks for all their clinical trials

N-SIDE introduces Lighthouse, innovative software to shape the future of worldwide clinical trial supply management

Lighthouse will double the amount of active clinical trials managed by N-SIDE to 1,400 within 3 years

green background with picture of pill tablets going to the trash

The hard balance between a short shelf life and low drug waste

A product's shelf life is a central part of every clinical trial. In some situations, shelf lives can become a problem for clinical supply chain managers,...

orange background with picture of empty pill tablets

Saving a trial from running into drug shortage

Although our solutions are ideally used proactively before the start of a trial to ensure a smooth sailing through the trial's lifecycle, we are sometimes called...

The challenges of a cell & gene therapy supply chain

Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 1] - The challenges of a cell & gene therapy supply...

Resources